Articles published by Innoviva, Inc.
![](https://mms.businesswire.com/media/20240904577524/en/2230979/22/new_innoviva_navy_resized_copy_%281%29.jpg)
Innoviva to Participate in Upcoming Investor Conferences
Today 7:00 EDT
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20240731216589/en/2201600/22/new_innoviva_navy_resized_copy.jpg)
Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
July 31, 2024
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20240603242707/en/2145539/22/new_innoviva_navy_resized_copy.jpg)
![](https://mms.businesswire.com/media/20240508594441/en/2122737/22/innoviva_navy_resized.jpg)
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
May 08, 2024
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20240508737674/en/2122767/22/innoviva_navy_resized_copy.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
February 29, 2024
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20231101529542/en/1932162/22/innoviva_navy_resized_copy_%281%29.jpg)
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 01, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20231011609335/en/1912158/5/Innoviva_Specialty_Therapeutics_Logo_RGB_FINAL.jpg)
![](https://mms.businesswire.com/media/20230919112391/en/1893305/22/innoviva_navy_resized_copy_%281%29.jpg)
Innoviva to Participate in the Cantor Global Healthcare Conference
September 19, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20230918666236/en/1891852/5/Innoviva_Specialty_Therapeutics_Logo_White_FINAL.jpg)
![](https://mms.businesswire.com/media/20230825912603/en/1875402/22/innoviva_navy_resized_copy_%281%29.jpg)
Innoviva Appoints Stephen Basso as Chief Financial Officer
August 25, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20230802433840/en/1857484/22/innoviva_navy_resized_copy_%281%29.jpg)
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 02, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20230606005949/en/1812472/22/Logo.jpg)
![](https://mms.businesswire.com/media/20230523005961/en/1801578/5/IST_RGB_WITH_TM.jpg)
![](https://mms.businesswire.com/media/20230511005905/en/1791666/22/Innoviva_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 09, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Innoviva Announces Retirement of Board Chairman
April 28, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20230417005846/en/1765842/22/Innoviva_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Innoviva Stock Trading Halted Today
April 17, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20230310005415/en/1736031/5/INVA_Logo.jpg)
![](https://mms.businesswire.com/media/20230228006203/en/1725766/5/INVA_Logo.jpg)
Innoviva Reports Fourth Quarter 2022 Financial Results and Highlights Recent Company Progress
February 28, 2023
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20221130006085/en/1651786/5/INVA_Logo.jpg)
Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)
November 30, 2022
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20221109005827/en/1631440/5/INVA_Logo.jpg)
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
November 09, 2022
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20220908005555/en/1565492/4/INVA.jpg)
Innoviva to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
September 08, 2022
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20220821005020/en/1549345/4/INVA.jpg)
Innoviva Completes Acquisition of La Jolla Pharmaceutical
August 22, 2022
From Innoviva, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220727005856/en/1526505/5/INVA_Logo.jpg)
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
July 27, 2022
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://mms.businesswire.com/media/20220713005562/en/1512573/5/INVA_Logo.jpg)
![](https://mms.businesswire.com/media/20220711005444/en/1509272/5/INVA_Logo.jpg)
Innoviva Completes Acquisition of Entasis Therapeutics
July 11, 2022
From Innoviva, Inc.
Via Business Wire
Tickers
INVA
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.